Suppr超能文献

血小板凝胶中生长因子释放动力学的定量评估。

Quantitative assessment of the kinetics of growth factors release from platelet gel.

作者信息

Su Chen Y, Kuo Ya P, Nieh Heng-Lu, Tseng Yu H, Burnouf Thierry

机构信息

Department of Dentistry, National Yang-Ming University, Taipei, Taiwan.

出版信息

Transfusion. 2008 Nov;48(11):2414-20. doi: 10.1111/j.1537-2995.2008.01862.x. Epub 2008 Aug 6.

Abstract

BACKGROUND

The time course of the release of growth factors from platelet (PLT) gels has not been thoroughly studied and should be elucidated for a better standardization of the clinical use of these products.

STUDY DESIGN AND METHODS

Release of PLT-derived growth factor-AB (PDGF-AB), transforming growth factor-beta1 (TGF-beta1), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and insulin-like growth factor-1 (IGF-1) was determined 5, 60, 120, and 300 minutes after PLT gel formation. Control experiments where PLT gel was removed and, afterward, exogenous thrombin was added, were also performed. Protein profiles of the PLT concentrates and of the releasates were determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).

RESULTS

Mean PDGF-AB, TGF-beta1, EGF, and VEGF concentration increased to 76, 114, 3.7, and 0.8 ng per mL, respectively, in the presence of the PLT gel, but remained at approximately 28, 30, 0.28, and 0.34 ng per mL, respectively, when the PLT gel was removed after formation. IGF-1 content remained unchanged (approx. 80 ng/mL). SDS-PAGE analysis showed that several PLT proteins disappear during PLT gel formation and that the protein patterns of the releasates were undistinguishable at the different time points.

CONCLUSION

There is a gradual and fast release of PDGF-AB, TGF-beta1, EGF, and VEGF from PLT gel for at least 60 to 300 minutes after gel formation, whereas the IGF releasate concentration remains unchanged. This study may provide useful information to improve clinical applications of PLT gels and to design improved blood-derived biomaterials with controlled release of growth factors.

摘要

背景

血小板(PLT)凝胶中生长因子的释放时间过程尚未得到充分研究,为更好地规范这些产品的临床应用,应对此进行阐明。

研究设计与方法

在PLT凝胶形成后5、60、120和300分钟测定血小板衍生生长因子-AB(PDGF-AB)、转化生长因子-β1(TGF-β1)、表皮生长因子(EGF)、血管内皮生长因子(VEGF)和胰岛素样生长因子-1(IGF-1)的释放情况。还进行了对照实验,即移除PLT凝胶后再添加外源性凝血酶。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)测定PLT浓缩物和释放物的蛋白质谱。

结果

在有PLT凝胶存在的情况下,平均PDGF-AB、TGF-β1、EGF和VEGF浓度分别增加至每毫升76、114、3.7和0.8纳克,但在凝胶形成后移除PLT凝胶时,它们分别保持在每毫升约28、30、0.28和0.34纳克。IGF-1含量保持不变(约80纳克/毫升)。SDS-PAGE分析表明,几种PLT蛋白在PLT凝胶形成过程中消失,且在不同时间点释放物的蛋白质模式无法区分。

结论

PLT凝胶形成后至少60至300分钟内,PDGF-AB、TGF-β1、EGF和VEGF从PLT凝胶中逐渐快速释放,而IGF释放物浓度保持不变。本研究可为改善PLT凝胶的临床应用以及设计具有生长因子控释功能的改良血液衍生生物材料提供有用信息。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验